ValuePickr Research Resources Basics

ValuePickr Forum

Granules India Ltd

Stock Opportunities Untested - but worth a good look

VIFL November 7, 2016, 5:15am 544

Shilpa Medicare -Racing away on the Oncology API highway! Not-so-Hidden Gems

The DMF filing upto Sep 30, 2016 is out and Shilpa has filed one DMF during the quarter (Q3CY16). Pirfenidone (gEsbriet): Innovator: Genentech (Roche Group) - www.esbriet.com Medicine for the treatment of idiopathic pulmonary fibrosis (IPF). The IPF market is currently dominated by only two drugs – Roche’s Esbriet & Boehringer Ingelheim’s Ofev. The top-selling drug in IPF in value terms is Roche’s Esbriet, which GlobalData estimates generated ~$572m in 2015. Esbriet has been retailing in US …

show post in topic

Home
Categories
FAQ/Guidelines
Terms of Service
Privacy Policy

Powered by Discourse, best viewed with JavaScript enabled